In our current study, metformin inhibited Rock2 by downregulating lncRNA-H19 and then activated HO-1/Nrf2 to inhibit oxidative stress injury induced by cerebral ischemia. The gene discussed is NFE2L2; the disease is Cerebral ischemia.